Study identification

EU PAS number

EUPAS1000000675

Study ID

1000000675

Official title and acronym

DARWIN EU® - Uptake of meningococcal vaccines by the target population in Europe

DARWIN EU® study

Yes

Study countries

Croatia
Denmark
Finland
Germany
Spain
United Kingdom

Study description

Immunisation against meningococcal disease forms a crucial public health measure in preventing IMD, especially amongst vulnerable populations.
Nevertheless, the coverage of meningococcal vaccines within Europe remains largely unclear and inconsistent due to the variation in the vaccination schedule recommended in countries within Europe and the UK.
This study aims to generate comprehensive evidence on the coverage of MenB, MenC, and MCV4 meningococcal vaccines as part of the immunisation schedule amongst eligible individuals in Europe.
The coverage of Meningococcal vaccines will be examined in countries including Croatia, Denmark, and Finland where Meningococcal vaccines are only administered to selected individuals with specific medical need and those with increased risk of meningococcal disease due to underlying health conditions or medications rather than as part of the routine vaccination schedule.
Given the administration of meningococcal vaccines provided to individuals outside the standard age-based immunisation schedule in certain countries, this study will additionally investigate the age distribution of vaccine receivals to identify patterns of off-schedule administration in separate countries across Europe.

Study status

Ongoing
Research institutions and networks

Institutions

Networks

Contact details

Ivan Lam

Primary lead investigator

Study timelines

Date when funding contract was signed

Planned:
Actual:

Study start date

Planned:
Actual:

Date of final study report

Planned:
Sources of funding
EMA
Regulatory

Was the study required by a regulatory body?

Yes

Is the study required by a Risk Management Plan (RMP)?

Not applicable